Back to the beginning: restarting infliximab in inflammatory bowel disease patients with prior loss of response. Clin Gastroenterol Hepatol 2014 Sep;12(9):1482-4
Date
04/17/2014Pubmed ID
24735794DOI
10.1016/j.cgh.2014.04.011Scopus ID
2-s2.0-84906791375 (requires institutional sign-in at Scopus site)Author List
Yarur AJ, Abreu MTMESH terms used to index this publication - Major topics in bold
AntibodiesAntibodies, Monoclonal
Female
Humans
Immunologic Factors
Inflammatory Bowel Diseases
Infliximab
Male
Pregnancy